top of page

Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates

  • Sep 26, 2024
  • 1 min read

Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective Therapeutics. Then, Jay Olson highlights ADC targets to watch while highlighting Bicycle and Sutro.



Brought to you by:


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page